These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22852848)

  • 1. Carvedilol protects against apoptotic cell death induced by cisplatin in renal tubular epithelial cells.
    Carvalho Rodrigues MA; Gobe G; Santos NA; Santos AC
    J Toxicol Environ Health A; 2012; 75(16-17):981-90. PubMed ID: 22852848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol protects against cisplatin-induced oxidative stress, redox state unbalance and apoptosis in rat kidney mitochondria.
    Rodrigues MA; Rodrigues JL; Martins NM; Barbosa F; Curti C; Santos NA; Santos AC
    Chem Biol Interact; 2011 Jan; 189(1-2):45-51. PubMed ID: 21044617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells.
    Yang C; Kaushal V; Shah SV; Kaushal GP
    Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1710-7. PubMed ID: 17311906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol protects against the renal mitochondrial toxicity induced by cisplatin in rats.
    Rodrigues MA; Rodrigues JL; Martins NM; Barbosa F; Curti C; Santos NA; Santos AC
    Mitochondrion; 2010 Jan; 10(1):46-53. PubMed ID: 19772951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol protects tubular epithelial cells from ischemia-reperfusion injury by inhibiting oxidative stress.
    Hayashi T; De Velasco MA; Saitou Y; Nose K; Nishioka T; Ishii T; Uemura H
    Int J Urol; 2010 Dec; 17(12):989-95. PubMed ID: 20946473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Blocker carvedilol protects cardiomyocytes against oxidative stress-induced apoptosis by up-regulating miR-133 expression.
    Xu C; Hu Y; Hou L; Ju J; Li X; Du N; Guan X; Liu Z; Zhang T; Qin W; Shen N; Bilal MU; Lu Y; Zhang Y; Shan H
    J Mol Cell Cardiol; 2014 Oct; 75():111-21. PubMed ID: 25066695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carvedilol efficiently protects kidneys without affecting the antitumor efficacy of cisplatin in mice.
    Carvalho Rodrigues MA; Silva Faria MC; Santos NA; Gobe GC; dos Santos AC
    Chem Biol Interact; 2013 Oct; 206(1):90-9. PubMed ID: 24012798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reversal of cisplatin-induced nephrotoxicity by selenium nanoparticles functionalized with 11-mercapto-1-undecanol by inhibition of ROS-mediated apoptosis.
    Li Y; Li X; Wong YS; Chen T; Zhang H; Liu C; Zheng W
    Biomaterials; 2011 Dec; 32(34):9068-76. PubMed ID: 21864903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro.
    Spallarossa P; Garibaldi S; Altieri P; Fabbi P; Manca V; Nasti S; Rossettin P; Ghigliotti G; Ballestrero A; Patrone F; Barsotti A; Brunelli C
    J Mol Cell Cardiol; 2004 Oct; 37(4):837-46. PubMed ID: 15380674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenylate cyclase-activating polypeptide ameliorates cisplatin-induced acute kidney injury.
    Li M; Balamuthusamy S; Khan AM; Maderdrut JL; Simon EE; Batuman V
    Peptides; 2010 Apr; 31(4):592-602. PubMed ID: 20034524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor modulates tubular cell survival in cisplatin nephrotoxicity.
    Tanaka T; Kojima I; Ohse T; Inagi R; Miyata T; Ingelfinger JR; Fujita T; Nangaku M
    Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1123-33. PubMed ID: 15956779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53.
    Wang J; Pabla N; Wang CY; Wang W; Schoenlein PV; Dong Z
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1300-7. PubMed ID: 16849690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cilastatin attenuates cisplatin-induced proximal tubular cell damage.
    Camano S; Lazaro A; Moreno-Gordaliza E; Torres AM; de Lucas C; Humanes B; Lazaro JA; Milagros Gomez-Gomez M; Bosca L; Tejedor A
    J Pharmacol Exp Ther; 2010 Aug; 334(2):419-29. PubMed ID: 20435919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of BMP-7 against aristolochic acid-induced renal tubular epithelial cell injury.
    Wang Z; Zhao J; Zhang J; Wei J; Zhang J; Huang Y
    Toxicol Lett; 2010 Oct; 198(3):348-57. PubMed ID: 20696222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carvedilol protects the kidneys of tumor-bearing mice without impairing the biodistribution or the genotoxicity of cisplatin.
    Carvalho Rodrigues MA; dos Santos NA; da Silva Faria MC; Rodrigues JL; Kinoshita A; Baffa O; Antunes LM; Barbosa F; Gobe GC; dos Santos AC
    Chem Biol Interact; 2016 Feb; 245():59-65. PubMed ID: 26751708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity.
    Yang C; Kaushal V; Haun RS; Seth R; Shah SV; Kaushal GP
    Cell Death Differ; 2008 Mar; 15(3):530-44. PubMed ID: 18064040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial/lysosomal toxic cross-talk plays a key role in cisplatin nephrotoxicity.
    Pourahmad J; Hosseini MJ; Eskandari MR; Shekarabi SM; Daraei B
    Xenobiotica; 2010 Nov; 40(11):763-71. PubMed ID: 20809784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of Glycine max and Chrysanthemum indicum extracts against cisplatin-induced renal epithelial cell death.
    Pongjit K; Ninsontia C; Chaotham C; Chanvorachote P
    Hum Exp Toxicol; 2011 Dec; 30(12):1931-44. PubMed ID: 21406484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamine protects against cisplatin-induced nephrotoxicity by decreasing cisplatin accumulation.
    Kim HJ; Park DJ; Kim JH; Jeong EY; Jung MH; Kim TH; Yang JI; Lee GW; Chung HJ; Chang SH
    J Pharmacol Sci; 2015 Jan; 127(1):117-26. PubMed ID: 25704027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G.
    Li S; Basnakian A; Bhatt R; Megyesi J; Gokden N; Shah SV; Portilla D
    Am J Physiol Renal Physiol; 2004 Nov; 287(5):F990-8. PubMed ID: 15280156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.